UNITE: Efficacy and impact of fremanezumab in patients with migraine and major depressive disorder

被引：0

作者：

Ramirez Campos, V. ^{[1
]}

Lipton, R. B. ^{[2
]}

Krasenbaum, L. J. ^{[1
]}

Ning, X. ^{[1
]}

Barbanti, P. ^{[3
,4
]}

Roth-Ben Arie, Z. ^{[5
]}

Galic, M. ^{[6
]}

Denysenko, L. ^{[7
,8
]}

Marmura, M. ^{[7
]}

McAllister, P. ^{[9
]}

Mitsikostas, D. D. ^{[10
]}

机构：

[1] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA

[2] Albert Einstein Coll Med, Dept Neurol Psychiat & Behav Sci, New York, NY USA

[3] IRCCS San Raffaele Roma, Headache & Pain Unit, Rome, Italy

[4] San Raffaele Univ, Rome, Italy

[5] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel

[6] TEVA PHARMA, Prod Farmaceut Lda, Porto Salvo, Portugal

[7] Thomas Jefferson Univ Hosp, Dept Neurol, Jefferson Headache Ctr, Philadelphia, PA 19107 USA

[8] Thomas Jefferson Univ Hosp, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA

[9] New England Inst Neurol & Headache, Stamford, CT USA

[10] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, Athens, Greece

来源：

JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P028

引用

页数：1

共 50 条

[41] Efficacy of agomelatine for anxiety symptoms in adult patients with major depressive disorder
Stein, D.
Chimits, D.
Picarel-Blanchot, F.
Khoo, J. P.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S59 - S60
[42] Impact of methodology on the efficacy of extended release quetiapine fumarate in major depressive disorder
Montgomery, S.
Kalali, A.
McIntyre, R. S.
Earley, W. R.
Nyberg, S.
Eriksson, H.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S353 - S353
[43] Migraine Predicts Self-Reported Muscle Tension in Patients With Major Depressive Disorder
Hung, Ching-I
Liu, Chia-Yih
Chen, Jane-Jane
Wang, Shuu-Jiun
PSYCHOSOMATICS, 2008, 49 (06) : 502 - 510
[44] The efficacy of vortioxetine for the treatment of major depressive disorder
Dhir, Ashish
Sarvaiya, Jayrajsinh
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (12) : 1349 - 1363
[45] The Impact of Fremanezumab on the Maximum Number of Consecutive Days Without Migraine in Patients with Episodic Migraine
Dodick, D. W.
Cohen, J. M.
Yang, R.
Ning, X.
HEADACHE, 2019, 59 : 112 - 113
[46] Molecular genetic overlap between migraine and major depressive disorder
Yang, Yuanhao
Zhao, Huiying
Boomsma, Dorret I.
Ligthart, Lannie
Belin, Andrea C.
Smith, George Davey
Esko, Tonu
Freilinger, Tobias M.
Hansen, Thomas Folkmann
Ikram, M. Arfan
Kallela, Mikko
Kubisch, Christian
Paraskevi, Christofidou
Strachan, David P.
Wessman, Maija
van den Maagdenberg, Arn M. J. M.
Terwindt, Gisela M.
Nyholt, Dale R.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 (08) : 1202 - 1216
[47] Is There an Association Between Migraine and Major Depressive Disorder? A Narrative Review
Jahangir, Saira
Adjepong, Dennis
All-Shami, Hieder A.
Malik, Bilal Haider
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
[48] Molecular genetic overlap between migraine and major depressive disorder
Yuanhao Yang
Huiying Zhao
Dorret I Boomsma
Lannie Ligthart
Andrea C. Belin
George Davey Smith
Tonu Esko
Tobias M. Freilinger
Thomas Folkmann Hansen
M. Arfan Ikram
Mikko Kallela
Christian Kubisch
Christofidou Paraskevi
David P. Strachan
Maija Wessman
Arn M. J. M. van den Maagdenberg
Gisela M. Terwindt
Dale R. Nyholt
European Journal of Human Genetics, 2018, 26 : 1202 - 1216
[49] Early efficacy of trazodone for the treatment of depressive episodes with mixed features in patients with major depressive disorder
Lo Serro, V.
Crapanzano, C.
Goracci, A.
Bolognesi, S.
Di Cicco, G.
Cini, E.
Carmellini, P.
Famularo, I.
Fagiolini, A.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S212 - S213
[50] Comorbid migraine in major depressive disorder suggests a subgroup related to bipolar disorder
Gordon-Smith, K.
Knott, S.
Perry, A.
Forty, L.
Craddock, N.
Jones, I.
Jones, L.
BIPOLAR DISORDERS, 2016, 18 : 85 - 85

← 1 2 3 4 5 →